Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 96

1.

Specific Expression of a New Bruton Tyrosine Kinase Isoform (p65BTK) in the Glioblastoma Gemistocytic Histotype.

Sala L, Cirillo G, Riva G, Romano G, Giussani C, Cialdella A, Todisco A, Virtuoso A, Cerrito MG, Bentivegna A, Grassilli E, Ardizzoia A, Bonoldi E, Giovannoni R, Papa M, Lavitrano M.

Front Mol Neurosci. 2019 Jan 24;12:2. doi: 10.3389/fnmol.2019.00002. eCollection 2019.

2.

[Next generation biobanking: the challenge of data].

Dagher G, Lavitrano ML, Hofman P.

Med Sci (Paris). 2018 Oct;34(10):849-851. doi: 10.1051/medsci/2018203. Epub 2018 Nov 19. Review. French.

PMID:
30451660
3.

Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation.

Riva G, Cilibrasi C, Bazzoni R, Cadamuro M, Negroni C, Butta V, Strazzabosco M, Dalprà L, Lavitrano M, Bentivegna A.

Genes (Basel). 2018 Oct 26;9(11). pii: E522. doi: 10.3390/genes9110522.

4.

Familiar unbalanced complex rearrangements involving 13 p-arm: description of two cases.

Conconi D, Villa N, Redaelli S, Sala E, Crosti F, Maitz S, Rigoldi M, Parini R, Dalprà L, Lavitrano M, Roversi G.

Mol Cytogenet. 2018 Sep 6;11:52. doi: 10.1186/s13039-018-0400-6. eCollection 2018.

5.

Metronomic combination of Vinorelbine and 5Fluorouracil is able to inhibit triple-negative breast cancer cells. Results from the proof-of-concept VICTOR-0 study.

Cerrito MG, De Giorgi M, Pelizzoni D, Bonomo SM, Digiacomo N, Scagliotti A, Bugarin C, Gaipa G, Grassilli E, Lavitrano M, Giovannoni R, Bidoli P, Cazzaniga ME.

Oncotarget. 2018 Jun 8;9(44):27448-27459. doi: 10.18632/oncotarget.25422. eCollection 2018 Jun 8.

6.

APOA-1Milano muteins, orally delivered via genetically modified rice, show anti-atherogenic and anti-inflammatory properties in vitro and in Apoe-/- atherosclerotic mice.

Romano G, Reggi S, Kutryb-Zajac B, Facoetti A, Chisci E, Pettinato M, Giuffrè MR, Vecchio F, Leoni S, De Giorgi M, Avezza F, Cadamuro M, Crippa L, Leone BE, Lavitrano M, Rivolta I, Barisani D, Smolenski RT, Giovannoni R.

Int J Cardiol. 2018 Nov 15;271:233-239. doi: 10.1016/j.ijcard.2018.04.029. Epub 2018 Jun 13.

7.

Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health.

Holub P, Kohlmayer F, Prasser F, Mayrhofer MT, Schlünder I, Martin GM, Casati S, Koumakis L, Wutte A, Kozera Ł, Strapagiel D, Anton G, Zanetti G, Sezerman OU, Mendy M, Valík D, Lavitrano M, Dagher G, Zatloukal K, van Ommen GB, Litton JE.

Biopreserv Biobank. 2018 Apr;16(2):97-105. doi: 10.1089/bio.2017.0110. Epub 2018 Jan 23. Review.

8.

19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update.

Nacinovich R, Villa N, Broggi F, Tavaniello C, Bomba M, Conconi D, Redaelli S, Sala E, Lavitrano M, Neri F.

Neuropsychiatr Dis Treat. 2017 Oct 4;13:2545-2550. doi: 10.2147/NDT.S142356. eCollection 2017.

9.

Liquid dynamic medicine and N-of-1 clinical trials: a change of perspective in oncology research.

Silvestris N, Ciliberto G, De Paoli P, Apolone G, Lavitrano ML, Pierotti MA, Stanta G; On the behalf of the “dynamic medicine OECI group”.

J Exp Clin Cancer Res. 2017 Sep 13;36(1):128. doi: 10.1186/s13046-017-0598-x. Review.

10.

Simultaneous overexpression of human E5NT and ENTPD1 protects porcine endothelial cells against H2O2-induced oxidative stress and cytotoxicity in vitro.

Chisci E, De Giorgi M, Zanfrini E, Testasecca A, Brambilla E, Cinti A, Farina L, Kutryb-Zajac B, Bugarin C, Villa C, Grassilli E, Combi R, Gaipa G, Cerrito MG, Rivolta I, Smolenski RT, Lavitrano M, Giovannoni R.

Free Radic Biol Med. 2017 Jul;108:320-333. doi: 10.1016/j.freeradbiomed.2017.03.038. Epub 2017 Apr 5.

11.

Microbiology Managers: Managerial Training in the RItrain Project.

Paterson RRM, Lima N, Brooksbank C, Guarini E, Pasterk M, Lavitrano M; RItrain project consortium.

Trends Microbiol. 2017 Jun;25(6):425-428. doi: 10.1016/j.tim.2017.03.002. Epub 2017 Mar 25.

12.

Resveratrol Impairs Glioma Stem Cells Proliferation and Motility by Modulating the Wnt Signaling Pathway.

Cilibrasi C, Riva G, Romano G, Cadamuro M, Bazzoni R, Butta V, Paoletta L, Dalprà L, Strazzabosco M, Lavitrano M, Giovannoni R, Bentivegna A.

PLoS One. 2017 Jan 12;12(1):e0169854. doi: 10.1371/journal.pone.0169854. eCollection 2017.

13.

Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential.

Conconi D, Chiappa V, Perego P, Redaelli S, Bovo G, Lavitrano M, Milani R, Dalprà L, Lissoni AA.

Oncol Rep. 2017 Jan;37(1):41-47. doi: 10.3892/or.2016.5274. Epub 2016 Nov 24.

14.

Quality Matters: 2016 Annual Conference of the National Infrastructures for Biobanking.

Doucet M, Becker KF, Björkman J, Bonnet J, Clément B, Daidone MG, Duyckaerts C, Erb G, Haslacher H, Hofman P, Huppertz B, Junot C, Lundeberg J, Metspalu A, Lavitrano M, Litton JE, Moore HM, Morente M, Naimi BY, Oelmueller U, Ollier B, Parodi B, Ruan L, Stanta G, Turano P, Vaught J, Watson P, Wichmann HE, Yuille M, Zaomi M, Zatloukal K, Dagher G.

Biopreserv Biobank. 2017 Jun;15(3):270-276. doi: 10.1089/bio.2016.0053. Epub 2016 Dec 19. No abstract available.

15.

Unexpected frequency of genomic alterations in histologically normal colonic tissue from colon cancer patients.

Conconi D, Redaelli S, Bovo G, Leone BE, Filippi E, Ambrosiani L, Cerrito MG, Grassilli E, Giovannoni R, Dalprà L, Lavitrano M.

Tumour Biol. 2016 Oct;37(10):13831-13842. Epub 2016 Aug 2.

16.

Epigenetic targeting of glioma stem cells: Short-term and long-term treatments with valproic acid modulate DNA methylation and differentiation behavior, but not temozolomide sensitivity.

Riva G, Butta V, Cilibrasi C, Baronchelli S, Redaelli S, Dalprà L, Lavitrano M, Bentivegna A.

Oncol Rep. 2016 May;35(5):2811-24. doi: 10.3892/or.2016.4665. Epub 2016 Mar 9.

PMID:
26986767
17.

The TGF-β pathway is activated by 5-fluorouracil treatment in drug resistant colorectal carcinoma cells.

Romano G, Santi L, Bianco MR, Giuffrè MR, Pettinato M, Bugarin C, Garanzini C, Savarese L, Leoni S, Cerrito MG, Leone BE, Gaipa G, Grassilli E, Papa M, Lavitrano M, Giovannoni R.

Oncotarget. 2016 Apr 19;7(16):22077-91. doi: 10.18632/oncotarget.7895.

18.

Using Copy Number Alterations to Identify New Therapeutic Targets for Bladder Carcinoma.

Conconi D, Sala E, Bovo G, Strada G, Dalprà L, Lavitrano M, Bentivegna A.

Int J Mol Sci. 2016 Feb 24;17(3):271. doi: 10.3390/ijms17030271.

19.

Nucleotide Catabolism on the Surface of Aortic Valve Xenografts; Effects of Different Decellularization Strategies.

Kutryb-Zajac B, Yuen AH, Khalpey Z, Zukowska P, Slominska EM, Taylor PM, Goldstein S, Heacox AE, Lavitrano M, Chester AH, Yacoub MH, Smolenski RT.

J Cardiovasc Transl Res. 2016 Apr;9(2):119-26. doi: 10.1007/s12265-016-9672-6. Epub 2016 Feb 1.

20.

A novel oncogenic BTK isoform is overexpressed in colon cancers and required for RAS-mediated transformation.

Grassilli E, Pisano F, Cialdella A, Bonomo S, Missaglia C, Cerrito MG, Masiero L, Ianzano L, Giordano F, Cicirelli V, Narloch R, D'Amato F, Noli B, Ferri GL, Leone BE, Stanta G, Bonin S, Helin K, Giovannoni R, Lavitrano M.

Oncogene. 2016 Aug 18;35(33):4368-78. doi: 10.1038/onc.2015.504. Epub 2016 Jan 25.

Supplemental Content

Loading ...
Support Center